Kohlberg Kravis Roberts - KKR

:

Pfizer (Capsugel business)

Dealogic Deal #  :

738954

Data as of :

4/4/2011

Target

Acquiror

Dates & Values

Pfizer (Capsugel business)

Kohlberg Kravis Roberts - KKR

Target:

100

% stake

Buying:

100

% stake

Rumored

-

Deal Value $m

2,375.0

Unlisted

0

0

m shares outstanding

Private (Not listed)

Announced

4th Apr 2011

Value ex Debt $m

2,375.0

United States

United States

Healthcare

Finance

Expected

3Q 2011

Consideration

Morgan Stanley | Advisor

Simpson Thacher | Attorney

Completed

-

Guggenheim Securities | Advisor

Cadwalader Wickersham | Attorney

Withdrawn

-

White & Case | Attorney

Termination Fee, Target $m

tbd

Termination Fee, Acquiror $m

tbd

Financials

-

Balance Sheet

Debt/Equity:

-

Timeline Events

Premiums & Multiples

Initial Offer

$0.00

Current Offer

-

Income Statement

Cash Flows

Operations $m

0

Profitability

Profit Margin

-

Return on Equity

-

League Table Impact

Sector Trend

2011 YTD Announced Global M&A by Deal Value, $bn

Monthly Announced Global M&A, $bn:

Healthcare

1

JPMorgan

217.1

2

Goldman Sachs

188.4

3

Morgan Stanley

168.7

4

Credit Suisse

158.9

5

Citi

142.9

6

Deutsche Bank

132.0

7

BOA Merrill Lynch

131.5

8

Lazard

113.0

9

Barclays Capital

104.8

10

UBS

96.1

59

Guggenheim

2.6

© 2011 Dealogic.  All rights reserved.